Drug Status: Marketed Drug
Nexium is a proton pump inhibitor (PPI) for the treatment of acid-related diseases.
For further information on Nexium and links to other product specific and disease area websites please click here.
Please consult the prescribing information for the country concerned on the approved use of drug.
- collapse An open-label, randomized, 4-treatment, 3-period, crossover interaction study, evaluating the effect of esomeprazole 40 mg, omeprazole 80 mg or lansoprazole 60 mg on the pharmacodynamics and the pharmacokinetics of clopidogrel in healthy volunteers
- collapse A Randomised, Single Blind, Two-way Cross-over, Single-centre Study to Assess the Pharmacodynamics (Intragastric pH) and Pharmacokinetics After Repeated Oral Administration of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects
- collapse A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination capsule of Esomeprazole 20 mg/Acetylsalicylic acid 81 mg
- collapse Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding
- collapse Prevalence of GERD in Patients with upperGITsymptoms in Thailand
- collapse A cross-sectional study on the prevalence of GERD in primary care patients with upper GI symptoms using the GERD-Q. The Bulgarian GERD-Q Study.
- collapse A randomized, double-blind, parallel group multicenter efficacy and safety phase IIB pilot study of Esomeprazole 40mg bid versus placebo bid in adult asthmatics treated for 4 months.
- collapse What is the value of the use of validated questionnaire (Reflux Impact Scale) for predicting treatment success with PPI.
- collapse A Multicenter, double -blind, Placebo-controlled Study to evaluate the effects of Esomeprazole 40mg bid on the signs and symptoms of Chronic Posterior Laryngitis with suspected Laryngopharyngeal Reflux.
- collapse Using an electronic health record-based intervention and broad education reach strategies to improve quality of care for GERD and gastroprotection for patients on NSAIDs: a randomized controlled trial
